Perfusion patterns of metastatic gastrointestinal stromal tumor lesions under specific molecular therapy

European Journal of Radiology

Volumn 77, Issue 2, 2011, Pages 312-318

  Schlemmer, Marcus ^a   Sourbron, Steven P ^a   Schinwald, Nicole ^a   Nikolaou, Konstantin ^a   Becker, Christoph R ^a   Reiser, Maximilian F ^a   Berger, Frank ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

CT perfusion; GIST; Sunitinib; Treatment monitoring

Indexed keywords

IMATINIB; SUNITINIB;

ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; LIVER INJURY; LIVER PERFUSION; MALE; MEMBRANE PERMEABILITY; METASTASIS; METASTATIC GASTROINTESTINAL STROMAL TUMOR; MOLECULAR THERAPY; MULTIPLE CYCLE TREATMENT; PERFUSION PHASE COMPUTER ASSISTED TOMOGRAPHY; PILOT STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE; VENOUS PHASE COMPUTER ASSISTED TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; ANTINEOPLASTIC AGENTS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INDOLES; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; PERFUSION IMAGING; PILOT PROJECTS; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES; PYRROLES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79953775815     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.07.031     Document Type: Article

References (28)

1. J. Rosai Gastrointestinal tract. Ackerman's surgical pathology 1996 Mosby Year-Book St Louis, MO
2. H. Joensuu, P.J. Roberts, and M. Sarlomo-Rikala Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor N Engl J Med 344 2001 1052 1056 (Pubitemid 32267975)
3. C. Le Tourneau, E. Raymond, and S. Faivre Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST) Ther Clin Risk Manage 3 2007 341 348 (Pubitemid 46881462)
4. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
5. H. Choi, C. Charnsangavej, and S. de Castro Faria CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings AJR Am J Roentgenol 183 2004 1619 1628 (Pubitemid 44210530)
6. R.S. Benjamin, H. Choi, and H.A. Macapinlac We should desist using RECIST, at least in GIST J Clin Oncol 25 2007 1760 1764 (Pubitemid 46797958)
7. T. Jin, H. Nakatani, and T. Taguchi STI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1 World J Gastroenterol 12 2006 703 708 (Pubitemid 43380751)
8. S. Faivre, G. Demetri, and W. Sargent Molecular basis for sunitinib efficacy and future clinical development Nat Rev Drug Discov 6 2007 734 745 (Pubitemid 47338181)
9. U. De Giorgi, C. Aliberti, and G. Benea Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors Clin Cancer Res 11 2005 6171 6176 (Pubitemid 41262944)
10. N. Lassau, M. Lamuraglia, and L. Chami Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography AJR Am J Roentgenol 187 5 2006 1267 1273 (Pubitemid 44630831)
11. K.A. Miles, C.A. Cuenod, Multidetector computed tomography in oncology 2007 Informa Healthcare London
12. H. Choi, C. Charnsangavej, and S.C. Faria Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria J Clin Oncol 25 2007 1753 1759 (Pubitemid 46797957)
13. S.P. Sourbron, H.J. Michaely, and M.F. Reiser MRI-measurement of perfusion and glomerular filtration in the human kidney with a separable compartment model Invest Radiol 43 2008 40 48
14. S. Shankar, E. vanSonnenberg, and J. Desai Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate Radiology 235 2005 892 898 (Pubitemid 40695886)
15. W.W. Ma, and A. Jimeno Temsirolimus Drugs Today (Barc) 43 2007 659 669 (Pubitemid 350220790)
16. B.E. Plaat, H. Hollema, and W.M. Molenaar Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins J Clin Oncol 18 2007 3211 3220
17. P.A. Cassier, A. Dufresne, and S. Arifi Imatinib mesilate for the treatment of gastrointestinal stromal tumour Expert Opin Pharmacother 9 2008 1211 1222 (Pubitemid 351721757)
18. A.D. Van den Abbeele The lessons of GIST-PET and PET/CT: a new paradigm for imaging The Oncologist 13 2008 8 13
19. G. Antoch, J. Kanja, and S. Bauer Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors J Nucl Med 45 2004 357 365 (Pubitemid 47618607)
20. I. Gayed, T. Vu, and R. Iyer The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors J Nucl Med 45 2004 17 21 (Pubitemid 47611603)
21. D.B. Mendel, A.D. Laird, and X. Xin In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship Clin Cancer Res 9 2003 327 337 (Pubitemid 36109749)
22. C.A. Cuenod, L. Fournier, and D. Balvay Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment Abdom Imaging 31 2006 188 193
23. Z. Kan, S. Phongkitkarun, and S. Kobayashi Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model Radiology 237 2005 151 158 (Pubitemid 41346159)
24. C. Stroszczynski, D. Jost, and P. Reichardt Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI Eur Radiol 15 2005 2448 2456 (Pubitemid 43153845)
25. L Yubao, and L. Chang Hong Gastrointestinal stromal tumor (GIST): correlatice study between 64-detector row CT perfusion and molecular pathology. Radiology Abstract at the Scientific Assembly and Annual Meeting of the Radiological Society of North America, abstract SSM09-03 2007
26. S. Stroobants, J. Goeminne, and M. Seegers 18FDG-positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec) Eur J Cancer 39 2003 2012 2020 (Pubitemid 37297757)
27. K.A. Miles, and R.E. Williams Warburg revisited: imaging tumour blood flow and metabolism Cancer Imaging 8 2008 81 86 (Pubitemid 351517291)
28. R.E. Pollard, A.R. Broumas, and E.R. Wisner Quantitative contrast-enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats Ultrasound Med Biol 33 2 2007 235 245 (Pubitemid 46240595)